Rebecca Dabora - Aug 5, 2021 Form 3 Insider Report for Adagio Therapeutics, Inc. (IVVD)

Role
Chief Technology Officer
Signature
/s/ Dorothy Vinsky, Attorney-in-Fact
Stock symbol
IVVD
Transactions as of
Aug 5, 2021
Transactions value $
$0
Form type
3
Date filed
8/5/2021, 09:16 PM
Next filing
Feb 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IVVD Stock Option (Right to Buy) Aug 5, 2021 Common Stock 331K $0.78 Direct F1
holding IVVD Stock Option (Right to Buy) Aug 5, 2021 Common Stock 570K $10.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One quarter (1/4) of the options shall vest on September 28, 2021, and thereafter, the remainder of the options shall vest in 36 equal monthly installments on the 28th day of each month, subject to the Reporting Person's continuous service on each vesting date.
F2 One quarter (1/4) of the options shall vest on May 7, 2022, and thereafter, the remainder of the options shall vest in 36 equal monthly installments on the 7th day of each month, subject to the Reporting Person's continuous service on each vesting date.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney